Addition of rituximab to TBI/CY improves the outcome of first-line autologous stem cell transplantation for mantle cell lymphoma

被引：0
|
作者：
Seyfarth, B
Boehme, V
Stuhlmann, R
Sonnen, R
Kneba, M
Schmitz, N
Dreger, P
机构：
[1] Allgemein Krankenhaus St Georg, Hamburg, Germany
[2] Univ Schleswig Holstein, Kiel, Germany
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [41] Rituximab in autologous stem cell transplantation for follicular lymphoma
    Schmitz, N
    ANTI-CANCER DRUGS, 2001, 12 : S21 - S24
  • [42] COST EFFECTIVENESS OF BORTEZOMIB, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE FOR THE FIRST-LINE TREATMENT OF MANTLE CELL LYMPHOMA NOT ELIGIBLE FOR STEM CELL TRANSPLANTATION: A SCOTTISH PERSPECTIVE
    Van Keep, M. M.
    Gairy, K.
    Seshagiri, D.
    Thilakarathne, P.
    Lee, D.
    VALUE IN HEALTH, 2015, 18 (07) : A453 - A453
  • [43] Rituximab Containing Autologous Stem Cell Transplantation May Be Curative in Mantle Cell Lymphoma for Patients in First Remission, but Not for Patients with Recurrent Disease
    Tam, Constantine S.
    Bassett, Roland
    Ledesma, Celina
    Korbling, Martin J.
    Okoroji, Grace-Julia
    Harrell, Robyn
    Hsu, Yvonne
    Silva, Leandro De Padua
    Alousi, Amin M.
    Hosing, Chitra M.
    Kebriael, Partow
    Rondon, Gabriela
    Giralt, Sergio
    De Lima, Marcos
    Anderlini, Paolo
    Popat, Uday
    Qazilbash, Muzaffar H.
    Samuels, Barry
    Champlin, Richard E.
    Khouri, Issa F.
    BLOOD, 2008, 112 (11) : 417 - 417
  • [44] Prognosis and outcome of stem cell transplantation for mantle cell lymphoma
    Cheminant, Morgane
    Robinson, Stephen
    Ribrag, Vincent
    Le Gouill, Steven
    Suarez, Felipe
    Delarue, Richard
    Hermine, Olivier
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (04) : 493 - 504
  • [45] Double autologous stem cell transplantation in mantle cell lymphoma.
    Bolaman, Z
    Kadikoylu, G
    Barutca, S
    Senturk, T
    BLOOD, 2001, 98 (11) : 390B - 390B
  • [46] Mantle cell lymphoma in patients not eligible for autologous stem cell transplantation
    Aurer, Igor
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (05) : 374 - 379
  • [47] Autologous Stem Cell Transplantation (ASCT) in Mantle Cell Lymphoma (MCL)
    Oinonen, R
    Jantunen, E
    Itälä, M
    Lehtinen, T
    Kuittinen, O
    Franssila, K
    Wiklund, T
    Elonen, E
    BONE MARROW TRANSPLANTATION, 2001, 27 : S258 - S258
  • [48] Autologous stem cell transplantation (ASCT) for mantle cell lymphoma (MCL).
    Conde, E
    Marco, F
    Caballero, D
    Arranz, R
    Lahuerta, JJ
    Sureda, A
    Bermudez, A
    Bosch, F
    García-Conde, J
    Marín, J
    Gandarillas, M
    Insunza, A
    León, A
    Zuazu, J
    Petit, J
    García-Laraña, J
    Gonzalez-Ponte, L
    Carrera, D
    Rubio-Félix, D
    Grande, C
    Gutierrez, M
    Varela, MR
    Pérez-Equiza, C
    Rifón, J
    Bello, JL
    Albo, C
    Ruiz, JCG
    Besalduch, J
    San Miguel, J
    Fernández-Rañada, JM
    Sierra, J
    Zubizarreta, A
    BLOOD, 2002, 100 (11) : 643A - 643A
  • [49] Rituximab Combined with Chemotherapy and Acalabrutinib Prior to Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: The Rectangle Trial
    Villa, Diego
    Larouche, Jean-Francois
    Cheung, Matthew C.
    Keating, Mary-Margaret
    Zukotynski, Katherine
    Tonseth, Petter
    Mayo, Samantha
    Laister, Robert
    Scott, David W.
    Kuruvilla, John
    BLOOD, 2023, 142
  • [50] Autologous stem cell transplantation and Rituximab independently prolong response duration in advanced stage mantle cell lymphoma
    Hoster, E.
    Metzner, B.
    Pfreundschuh, M.
    Truemper, L.
    Hallek, M.
    Woermann, B.
    Duehrsen, U.
    Gisselbracht, C.
    Kluin-Nelemans, J. C.
    Van Hoof, A.
    Unterhalt, M.
    Hiddemann, W.
    Dreyling, M.
    ONKOLOGIE, 2010, 33 : 202 - 202
12345